Supporting the best doctors with the most advanced cancer therapies
“Immunotherapy is the future of cancer health.”
Dendritic cell therapy is considered to be the most effective immunotherapy. Despite its longevity and results distribution and accessibility is still very limited. Immucura targets to make DCT available to as many countries and patients as possible.
Doctors, clinics, hospitals
Partners benefit from
Including Dendritic Cell Therapy as an advanced option for cancer patients
Precise information about the therapy and clear instructions on how to apply it
Training of doctors and medical staff
Privileged access to the team of experts
Information material for patients
Depending on local regulation
Safe and fast transport of the blood samples to the laboratory and back in 9 to 11 days
Support programs for patients for a 14-day therapy stay to Spain and receive therapy report for further observation and treatments
Remuneration for clinical studies.
To give patients the best advice, access the database of clinical studies
Set up of research projects and clinical studies
Training of students within internship programs
Offering trailblazing therapy with positive public reputation
Looking for the latest therapy against cancer on the market to offer to clients?
The Costa del Sol is the best spot for recovery that patients could look for combined it with the heartwarming individual care. Contact to start collaborating with Immucura Med.
Future team members
Scientists in immunotherapy (Biochemistry) (Germany)
Medical Administration Expert (Spain)
Online Media Producer (Spain, Gibraltar)
Head office and medical center Spain:
Avenida de España 22, 29649
Mijas (Malaga), Spain.